Jove
Visualize
Contact Us

Related Experiment Videos

Beta blocking drugs as anti-arrhythmic agents.

J D Fitzgerald

    International Journal of Clinical Pharmacology and Biopharmacy
    |April 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Beta-adrenergic blocking drugs demonstrate significant anti-arrhythmic activity. They are primarily used to control heart rhythm disorders like sinus tachycardia and rapid ventricular rates by blocking catecholamine effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Exercise Interventions for Preserving Physical Function Among Cancer Survivors in Middle to Late Life.

    The Journal of frailty & aging·2016
    Same author

    Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.

    Cold Spring Harbor perspectives in medicine·2014
    Same author

    Assessment and clinical implications of cardioselectivity.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis.

    Lupus·2008
    Same author

    SMI meeting: innovations in cardiovascular drugs. March 3-4, 1999, London, UK.

    Expert opinion on investigational drugs·2005
    Same author

    Distortion of the spermathecae of phytoseiid mites (Acari: Phytoseiidae) in slide preparation.

    Experimental & applied acarology·2001
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Beta-adrenergic blocking drugs have been in clinical use for fifteen years.
    • Evidence supports their significant anti-arrhythmic properties.

    Purpose of the Study:

    • To summarize the established clinical applications and mechanism of action of beta-adrenergic blocking drugs in managing cardiac dysrhythmias.

    Main Methods:

    • Review of clinical evidence and pharmacological data regarding beta-adrenergic blocking drugs.
    • Analysis of their efficacy in treating specific cardiac rhythm disorders.

    Main Results:

    • Beta-adrenergic blockers are effective in controlling sinus tachycardia and digitalis-induced dysrhythmias.
    • They also manage rapid ventricular rates in atrial and ventricular dysrhythmias.

    Related Experiment Videos

    Conclusions:

    • Beta-adrenergic blocking drugs are valuable therapeutic agents for various cardiac rhythm disturbances.
    • Their mechanism involves antagonizing catecholamine actions on cardiac automaticity and conduction.